Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)

NCT00427856 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Follicular

Interventions

DRUG: Obatoclax mesylate
DRUG: Rituximab

Sponsor

Gemin X